HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valerie-Jeanne Bardou Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

11/2004CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valerie-Jeanne Bardou Research Topics

Disease

2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2005 - 07/2004
1Disease Progression
02/2013
1Hematologic Neoplasms (Hematological Malignancy)
02/2013
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2004
1Neoplasms (Cancer)
05/2003
1Breast Neoplasms (Breast Cancer)
05/2003

Drug/Important Bio-Agent (IBA)

1Busulfan (Busulfex)FDA Link
02/2013
1HLA Antigens (Human Leukocyte Antigens)IBA
02/2013
1fludarabineIBA
02/2013
1thymoglobulinFDA Link
02/2013
1Progesterone Receptors (Progesterone Receptor)IBA
05/2003
1Estrogen ReceptorsIBA
05/2003

Therapy/Procedure

1Transplantation
02/2013
1Stem Cell Transplantation
10/2005
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
11/2004
1Homologous Transplantation
11/2004
1Induction Chemotherapy
07/2004
1Palliative Care (Palliative Therapy)
07/2004
1Therapeutics
05/2003